A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104).
Saved in:
| Title: | A Phase I/II study of suberoylanilide hydroxamic acid (SAHA) in combination with trastuzumab (Herceptin) in patients with advanced metastatic and/or local chest wall recurrent HER2-amplified breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1104). |
|---|---|
| Authors: | Goldstein LJ; Fox Chase Cancer Center, Philadelphia, PA, USA. lori.goldstein@fccc.edu., Zhao F; Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Wang M; Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, MA, USA., Swaby RF; Fox Chase Cancer Center, Philadelphia, PA, USA.; Merck Pharmaceuticals, North Wales, PA, USA., Sparano JA; West Chester Medical Center, Valhalla, NY, USA., Meropol NJ; Fox Chase Cancer Center, Philadelphia, PA, USA.; University Hospitals Case Medical Center, Cleveland, OH, USA., Bhalla KN; MD Anderson Cancer Center, Houston, TX, USA.; Georgia Regents University NCORP, Augusta, Georgia., Pellegrino CM; West Chester Medical Center, Valhalla, NY, USA., Katherine Alpaugh R; Fox Chase Cancer Center, Philadelphia, PA, USA., Falkson CI; University of Alabama, Birmingham, AL, England, UK., Klein P; Beth Israel Medical Center, New York, USA.; St. Vincent's Comp. Cancer Center, New York, USA., Sledge GW; Stanford University, Stanford, CA, USA.; Indiana University Cancer Center, Indianapolis, IN, USA. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2017 Sep; Vol. 165 (2), pp. 375-382. Date of Electronic Publication: 2017 Jun 16. |
| Publication Type: | Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1573-7217 |
|---|---|
| DOI: | 10.1007/s10549-017-4310-9 |
